Medio de suero reducido Opti-MEM™ I
Medio de suero reducido Opti-MEM™ I
Gibco™

Medio de suero reducido Opti-MEM™ I

El medio de suero reducido Opti-MEM™ I es un medio esencial mínimo (MEM) mejorado que permite una reducción de laMás información
Have Questions?
Cambiar vistabuttonViewtableView
Número de catálogoCantidad
3198508810 × 500 mL
31985070500 mL
31985062100 mL
Número de catálogo 31985088
Precio (MXN)
-
Cantidad:
10 × 500 mL
Customize this product
El medio de suero reducido Opti-MEM™ I es un medio esencial mínimo (MEM) mejorado que permite una reducción de la suplementación de suero bovino fetal, por lo menos en un 50 %, sin ningún cambio en la tasa de crecimiento o la morfología. El medio Opti-MEM™ I también se recomienda cuando se van a usar reactivos de transfección de lípidos catiónicos, como el reactivo Lipofectamine™. El medio Opti-MEM™ I se puede emplear con diversas células de mamíferos adherentes y en suspensión, incluidos SP2, AE-1, CHO, BHK-21, HEK y fibroblastos primarios. Ofrecemos diversas modificaciones de Opti-MEM™ I para diferentes aplicaciones de cultivos celulares.

Esta versión de Opti-MEM™ I se ha modificado del modo siguiente:
Con
• L-glutamina
• Rojo de fenol

La formulación completa es confidencial. Si desea obtener más información, póngase en contacto con el servicio técnico.

Uso del medio Opti-MEM™ I
El medio de suero reducido Opti-MEM™ I es un medio único que contiene insulina, transferrina, hipoxantina, timidina y oligoelementos. Estos componentes adicionales permiten una reducción en la suplementación sérica de al menos un 50 %. El medio Opti-MEM™ I utiliza un sistema de tampones de bicarbonato sódico (2,4 g/l) y, por tanto, requiere un ambiente con un 5–10 % de CO2 para mantener el pH fisiológico.

Sistema cGMP de elaboración y calidad
Opti-MEM™ I se elabora en unas instalaciones que cumplen con las buenas prácticas de fabricación actuales ubicadas en Grand Island, Nueva York (EE. UU.). Las instalaciones se han registrado en la Agencia estadounidense de alimentos y medicamentos (FDA) como fabricante de dispositivos médicos y tienen la certificación según la norma ISO 13485. Para mantener la continuidad de la cadena de suministro, ofrecemos un producto Opti-MEM™ I idéntico fabricado en nuestras instalaciones de Escocia (31985-047). Estas instalaciones también se han registrado en la FDA como fabricante de dispositivos médicos y tienen la certificación según la norma ISO 13485.
Para su uso en investigación o procesos de fabricación posteriores. No apto para uso diagnóstico ni para la administración directa en seres humanos ni en animales.
Especificaciones
Línea de célulasSp2, AE-1, CHO, BHK-21, and HEK
Tipo de célulaPrimary Fibroblasts
Concentración1 X
Calidad de fabricacióncGMP-compliant under the ISO 13485 standard
Línea de productosGibco, Opti-MEM
Tipo de productoOpti-MEM I
Cantidad10 × 500 mL
Duración de almacenamiento18 Months From Date of Manufacture
Condiciones de envíoTemperatura ambiente
ClasificaciónHuman Origin
FormularioLíquido
EsterilidadEstéril con filtro
Sterilization MethodSterile-filtered
Con aditivosGlutamine, Phenol Red
Unit SizeEach
Contenido y almacenamiento
Store at 2–8°C and protect from light.

Preguntas frecuentes

What should I use to dilute my RNAi duplexes and Lipofectamine RNAiMAX before complexing?

We recommend using Opti-MEM I Reduced Serum Medium (Cat. No. 31985062).

Find additional tips, troubleshooting help, and resources within our Transfection Support Center.

Do you offer an alternative for Opti-MEM I Reduced Serum Medium (Cat. No. 31985070)?

Opti-MEM I Reduced Serum Medium, no phenol red (Cat. No. 11058021) would be the closest alternative. Both offerings contain L-glutamine. For more a stabilized L-glutamine option, Opti-MEM I Reduced Serum Medium, GlutaMAX Supplement (Cat. No. 51985034) is the recommended alternative. All Opti-MEM offerings have demonstrated performance for both reduced-serum cell culture and lipid-based transfection.

My OpitMEM Reduced Serum Medium (Cat. No. 31985070) was accidentally frozen. Can I still use it?

This product should be stored at 2-8 degrees C and should not be frozen. The biggest issue with accidentally freezing this product is its solubility. If this product was accidentally frozen, we recommend placing it in a 2-8 degree environment and allowing it to slowly thaw overnight. If the product is fully thawed and shows no signs of precipitation, then it should still be usable, but we cannot guarantee effectiveness.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

Is there any other difference between Opti-MEM I Reduced Serum Medium and Opti-MEM I Reduced Serum Medium, no phenol red besides the presence/absence of phenol red?

The formulation of Opti-MEM I Reduced Serum Medium and that of Opti-MEM I Reduced Serum Medium, no phenol red is the same except for the presence of phenol red in the former medium.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

Where can I find the osmolality for my lot of Opti-MEM I Reduced Serum Medium?

We do provide osmolality information on the certificate of analysis. All lots of Opti-MEM I Reduced Serum Medium will meet the osmolality specification of ≥280 to ≤320 mOsm/kg.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

Citations & References (5)

Citations & References
Abstract
Identification of a novel redox-sensitive gene, Id3, which mediates angiotensin II-induced cell growth.
Authors:Mueller Cornelius; Baudler Stephanie; Welzel Hilke; Böhm Michael; Nickenig Georg;
Journal:Circulation
PubMed ID:12021231
BACKGROUND: Reactive oxygen species, such as superoxide (O(2)(-)), are involved in the abnormal growth of various cell types. Angiotensin II (Ang II) is one of the most potent inducers of oxidative stress in the vasculature. The molecular events involved in Ang II-induced proliferation of vascular smooth muscle cells (VSMCs) are ... More
Regulation of cortical dendrite development by Slit-Robo interactions.
Authors:Whitford Kristin L; Marillat Valérie; Stein Elke; Goodman Corey S; Tessier-Lavigne Marc; Chédotal Alain; Ghosh Anirvan;
Journal:Neuron
PubMed ID:11779471
Slit proteins have previously been shown to regulate axon guidance, branching, and neural migration. Here we report that, in addition to acting as a chemorepellant for cortical axons, Slit1 regulates dendritic development. Slit1 is expressed in the developing cortex, and exposure to Slit1 leads to increased dendritic growth and branching. ... More
Cloning and characterization of freac-9 (FKHL17), a novel kidney-expressed human forkhead gene that maps to chromosome 1p32-p34.
Authors: Ernstsson S; Betz R; Lagercrantz S; Larsson C; Ericksson S; Cederberg A; Carlsson P; Enerbäck S;
Journal:Genomics
PubMed ID:9403061
'We describe the cloning of a near full-length cDNA of 4258 nucleotides encoding freac-9 (HGMW-approved symbol FKHL17), a novel human forkhead gene. The 5'' untranslated region is unusual since it is very long, 2127 nucleotides, and contains 15 upstream AUG codons. Hybridization to a panel consisting of RNA derived from ... More
Noninfectious virus-like particles produced by Moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents.
Authors:Sharma S, Murai F, Miyanohara A, Friedmann T
Journal:Proc Natl Acad Sci U S A
PubMed ID:9380714
Retrovirus packaging cell lines expressing the Moloney murine leukemia virus gag and pol genes but lacking virus envelope genes produce virus-like particles constitutively, whether or not they express a transcript from an integrated retroviral provirus. In the absence of a proviral transcript, the assembled particles contain processed gag and reverse ... More
Human T-cell leukemia virus type I Tax protein transactivates RNA polymerase III promoter in vitro and in vivo.
Authors: Piras G; Dittmer J; Radonovich M F; Brady J N;
Journal:J Biol Chem
PubMed ID:8702791
Tax protein of the human T-cell lymphotropic virus type 1 (HTLV-I) is critical for viral replication and is a potent transcriptional activator of viral and cellular polymerase II (pol II) genes. We report here that Tax is able to transactivate a classical pol III promoter, VA-I. In cotransfection experiments, Tax ... More